Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

ACA vs TPCS: stock comparison and AI forecast

Arcosa, Inc. (ACA) and Techprecision Corp (TPCS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Fabricated Structural Metal Products

ACA Arcosa, Inc.

Price
$149.15 +28.1% · 6M
Market Cap
$7.32B
P/E Ratio
15.4x
Size
mid-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Nasdaq · Fabricated Structural Metal Products

TPCS Techprecision Corp

Price
$5.02 +21.8% · 6M
Market Cap
$51M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-10-29

Six-month price performance

Closing prices rebased to 100 at the start of the window.

90105120135150
ACA +28.1% TPCS +21.8%
ACA · TPCS

Key facts

  • ACA is 144.5 times larger than TPCS by market capitalization ($7.32B against $51M).
  • Over the last six months ACA returned +28.1% and TPCS +21.8%.
  • ACA turns 17.9% of its revenue into net income, against -4.5% for TPCS.
  • TPCS carries 3.10 times debt per unit of equity, against 0.78 times for ACA.
  • ACA yields 0.14% in dividends; TPCS pays none.
  • Both companies share the SEC industry classification Fabricated Structural Metal Products.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricACATPCS
Market Cap$7.32B$51M
P/E Ratio15.39x–
P/B Ratio2.46x6.66x
Dividend Yield0.14%–
EPS$9.69$-0.19
Book Value/Share$60.75$0.75
Revenue/Share$55.90$4.03
FCF/Share$2.75$-0.38

Profitability & Margins

MetricACATPCS
ROE16.5%-23.9%
ROA9.3%-5.8%
ROIC6.7%-8.0%
Gross Margin23.0%15.7%
Operating Margin11.8%-2.7%
Net Margin17.9%-4.5%
EBT Margin8.3%-4.4%
Tax Rate13.1%-1.7%

Financial Health

MetricACATPCS
Current Ratio3.12x1.00x
Quick Ratio2.31x0.88x
D/E Ratio0.78x3.10x
Financial Leverage1.78x4.10x
Interest Coverage3.6x-0.5x
Working Capital$959M-$50K

Cash Flow

MetricACATPCS
Operating Cash Flow$341M$2M
Free Cash Flow$135M-$4M
Capital Spending-$206M-$6M
OCF Growth YoY-23.1%4.3%
FCF Growth YoY-54.0%–
FCF/Sales4.9%-9.3%
CapEx/Sales7.5%14.0%

Operational Efficiency

MetricACATPCS
Asset Turnover0.52x1.30x
Receivables Turnover4.9x13.3x
Inventory Turnover5.8x17.0x
Fixed Assets Turnover1.3x3.9x
Days Sales Outstanding74 days28 days
Days Inventory63 days22 days
Payables Period39 days37 days
Cash Conversion Cycle99 days12 days

Income Statement

MetricACATPCS
Total Revenue$2.74B$41M
Operating Income$323M-$1M
Net Income$491M-$2M
SG&A Expense$325M$7M
Cost of Goods Sold$2.11B$34M

Dividend & Shareholder Information

MetricACATPCS
Dividends Per Share$0.20–
Payout Ratio2.1%–
Shares Outstanding49M10M
Net Income Growth433.0%–
EPS Growth340.4%–
FAQ

ACA vs TPCS: stock comparison and AI forecast

Which is bigger, ACA or TPCS?

ACA is 144.5 times larger than TPCS by market capitalization ($7.32B against $51M).

Which stock performed better over the last six months, ACA or TPCS?

Over the last six months ACA returned +28.1% and TPCS +21.8%.

Which one does Intratio's AI model rank higher, ACA or TPCS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.